BioAtla Operating Expenses Growth & History (BCAB)
BioAtla's operating expenses was $61.3M for fiscal 2025.
View full BioAtla company overviewBioAtla annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $61.3M | −$23.6M | −27.83% |
| 2024 | 2024-12-31 | $84.9M | −$44.7M | −34.50% |
| 2023 | 2023-12-31 | $129.7M | $21.5M | +19.93% |
| 2022 | 2022-12-31 | $108.1M | $11.4M | +11.84% |
| 2021 | 2021-12-31 | $96.7M | $66.2M | +216.73% |
| 2020 | 2020-12-31 | $30.5M | −$2.9M | −8.78% |
| 2019 | 2019-12-31 | $33.5M | — | — |
BioAtla quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.3M | −$12.4M | −66.36% |
| Q1 2026 | 2026-03-31 | $9.3M | −$8.3M | −47.16% |
| Q4 2025 | 2025-12-31 | $11.3M | −$5.0M | −30.71% |
| Q3 2025 | 2025-09-30 | $13.8M | −$8.5M | −38.08% |
| Q2 2025 | 2025-06-30 | $18.6M | −$3.3M | −15.13% |
| Q1 2025 | 2025-03-31 | $17.6M | −$6.8M | −27.98% |
| Q4 2024 | 2024-12-31 | $16.2M | −$12.3M | −43.08% |
| Q3 2024 | 2024-09-30 | $22.3M | −$12.8M | −36.41% |
| Q2 2024 | 2024-06-30 | $22.0M | −$15.2M | −40.94% |
| Q1 2024 | 2024-03-31 | $24.5M | −$4.5M | −15.46% |
| Q4 2023 | 2023-12-31 | $28.5M | −$24,000 | −0.08% |
| Q3 2023 | 2023-09-30 | $35.0M | $8.8M | +33.77% |
| Q2 2023 | 2023-06-30 | $37.2M | $8.1M | +28.04% |
| Q1 2023 | 2023-03-31 | $28.9M | $4.6M | +18.83% |
| Q4 2022 | 2022-12-31 | $28.6M | $5.1M | +21.59% |
| Q3 2022 | 2022-09-30 | $26.2M | $2.5M | +10.48% |
| Q2 2022 | 2022-06-30 | $29.1M | −$1.7M | −5.39% |
| Q1 2022 | 2022-03-31 | $24.3M | $5.5M | +29.52% |
| Q4 2021 | 2021-12-31 | $23.5M | $7.0M | +42.74% |
| Q3 2021 | 2021-09-30 | $23.7M | $15.5M | +190.20% |
| Q2 2021 | 2021-06-30 | $30.7M | $26.0M | +552.02% |
| Q1 2021 | 2021-03-31 | $18.8M | $17.6M | +1469.03% |
| Q4 2020 | 2020-12-31 | $16.5M | — | — |
| Q3 2020 | 2020-09-30 | $8.2M | — | — |
| Q2 2020 | 2020-06-30 | $4.7M | — | — |
| Q1 2020 | 2020-03-31 | $1.2M | — | — |
BioAtla operating expenses trends
Over the last five fiscal years, BioAtla's operating expenses increased from $30.5M to $61.3M, a change of $30.8M. The latest reported quarter, Q2 2026, shows $6.3M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioAtla source filings ↗